A detailed history of Moody Aldrich Partners LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 3,475 shares of UTHR stock, worth $1.11 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,475
Previous 2,024 71.69%
Holding current value
$1.11 Million
Previous $445,000 79.33%
% of portfolio
0.15%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$210.76 - $249.51 $305,812 - $362,039
1,451 Added 71.69%
3,475 $798,000
Q3 2023

Nov 07, 2023

BUY
$211.82 - $248.24 $428,723 - $502,437
2,024 New
2,024 $457,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.